| scholarly article | Q13442814 |
| P2093 | author name string | Diaa T A Youssef | |
| Khalid A El Sayed | |||
| Dario Marchetti | |||
| P433 | issue | 2 | |
| P921 | main subject | latrunculin B | Q4255012 |
| P304 | page(s) | 219-223 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Journal of Natural Products | Q165584 |
| P1476 | title | Bioactive natural and semisynthetic latrunculins | |
| P478 | volume | 69 |
| Q34054363 | 3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches |
| Q37945009 | A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2010. |
| Q39394159 | An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs. |
| Q50043649 | Antimicrobial, antioxidant, and antimutagenic activities of selected marine natural products and tobacco cembranoids |
| Q61971284 | Base-Promoted Sulfur-Mediated Carbonylative Cyclization of Propargylic Amines |
| Q56872260 | Cancer cells' ability to mechanically adjust to extracellular matrix stiffness correlates with their invasive potential |
| Q33674177 | Development and validation of a rapid method for the detection of latrunculol A in plasma |
| Q35957698 | Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds. |
| Q42586263 | Efficacy of some natural compounds as antifungal agents |
| Q28533449 | Exploring anti-bacterial compounds against intracellular Legionella |
| Q38954839 | In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor. |
| Q34092083 | Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells |
| Q33262990 | Latrunculin analogues with improved biological profiles by "diverted total synthesis": preparation, evaluation, and computational analysis |
| Q36862758 | Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking. |
| Q33834080 | Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. |
| Q33980259 | Marine Natural Products as Inhibitors of Hypoxic Signaling in Tumors |
| Q37327189 | Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous |
| Q34086801 | Natural product libraries to accelerate the high-throughput discovery of therapeutic leads |
| Q37435956 | Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity. |
| Q36485483 | Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies |
| Q46246075 | The Potential of Indonesian Heterobranchs Found around Bunaken Island for the Production of Bioactive Compounds |
| Q53589334 | Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B. |
Search more.